ChainCatcher news, reported by PR Newswire, Bitcoin investment company Parataxis Holdings LLC announced that it has reached a final investment agreement of 25 billion Korean won with Bridge Biotherapeutics, Inc.

The transaction gives it control of the latter, and after the deal is completed, Bridge Biotherapeutics will be renamed Parataxis Korea and continue to be listed on the Korean KOSDAQ startup market. The company is expected to announce more details about this transaction after holding a shareholders' meeting in August.